SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
136 hedge funds and large institutions have $205M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 51 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+2
Holders Change %
+1.49%
% of All Funds
3.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
24
Increased
44
Reduced
51
Closed
19
Calls
$583K
Puts
$469K
Net Calls
+$114K
Net Calls Change
-$1.27M
Top Buyers
| 1 |
KAM
Krensavage Asset Management
New York
|
+$11.8M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$3.93M |
| 3 |
RA
Royce & Associates
New York
|
+$3.84M |
| 4 |
Renaissance Technologies
New York
|
+$3.09M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$2.8M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.47M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$8.11M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.39M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.53M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.71M |
